Skip to main content
Log in

Role of altered prednisolone-specific lymphocyte sensitivity in chronic renal failure as a pharmacodynamic marker of acute allograft rejection after kidney transplantation

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effects of four immunosuppressive agents on the in vitro blastogenesis of peripheral blood lymphocytes activated by concanavalin A have been studied using cells from 26 healthy subjects, 34 patients with chronic renal failure (CRF) and 30 kidney transplant recipients.

Differences in lymphocyte sensitivity to prednisolone between the healthy subjects and the CRF patients were statistically significant (P<0.0002), with impaired sensitivity in CRF. Impaired lymphocyte sensitivity occurred in 3.8% and 52.9% of the healthy and CRF subjects, respectively. Lymphocyte sensitivity to prednisolone, both preoperatively and 3 months post-operatively, was strongly correlated with early allograft rejection during co-administration of prednisolone with cyclosporin or azathioprine. Lymphocyte sensitivity to cyclosporin, azathioprine, and mizoribine in CRF was not significantly less than that in healthy subjects.

Since the pharmacokinetics of prednisolone are little altered in renal transplantation, it is concluded that lymphocyte sensitivity specific to prednisolone may be a pharmacodynamic marker characteristic of successful graft survival in patients with histo-incompatibility and/or drug resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Öst L, Björkhem I, von Bahr C (1984) Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation. Eur J Clin Parmacol 26: 363–369

    Google Scholar 

  2. Langhoff E, Hvidberg EF, Flachs H, Ladefoged J (1987) Glucocorticoid levels and lymphocyte functions in kidney transplanted patients. Pharmacol Toxicol 60: 269–273

    Google Scholar 

  3. Gambertoglio JG, Amend WJC, Benet LZ (1980) Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients. A review. J Pharmacokinet Biopharm 8: 1–52

    Google Scholar 

  4. Frey BM, Frey FJ, Holford NHG, Lozada F, Benet LZ (1982) Prednisolone pharmacodynamics assessed by inhibition of the mixed lymphocyte reaction. Transplantation 33: 578–584

    Google Scholar 

  5. Oosterhuis B, ten Berge RJM, Sauerwein HP, Endert E, Schellekens PTA, van Boxtel CJ (1984) Pharmacokinetic-pharmacodynamic modeling of prednisolone induced lymphocytopenia in man. J Pharmacol Exp Ther 229: 539–546

    Google Scholar 

  6. Schuyler MR, Gerblich A, Urda G (1984) Prednisone and T-cell subpopulations. Arch Intern Med 144: 973–975

    Google Scholar 

  7. Frey BM, Walker C, Frey FJ, de Weck AL (1984) Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J Immunol 133: 2479–2487

    Google Scholar 

  8. Bowes LG, Dumble LJ, Francis GJA, Macdonald IM, Kincaid-Smith P (1988) Lymphoid resistant responses to in vitro immunosuppression in renal transplant recipients: increase of refractory episodes. Transplant Proc 20: 20–22

    Google Scholar 

  9. Langhoff E, Ladefoged J (1987) The impact of high lymphocyte sensitivity to glucocorticoids on kidney graft survival in patients treated with azathioprine and cyclosporine. Transplantation 43: 380–384

    Google Scholar 

  10. Langhoff E, Ladefoged J, Jakobsen BK, Platz P, Ryder LP, Svejgaard A, Thaysen JH (1986) Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival. Lancet I: 1296–1297

    Google Scholar 

  11. Oka K, Hosoda K, Hirano T, Sakurai E, Kozaki M (1989) Determination of cyclosporin A in the serum of kidney transplant patients by rapid-flow fractionation and normal-phase high-performance liquid chromatography. J Chromatogr Biomed Appl 490: 145–154

    Google Scholar 

  12. Lowy MT, Reder AT, Antel JP, Meltzer HY (1984) Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone. Am J Psychiat 141: 1365–1370

    Google Scholar 

  13. Potter JM, House AK, Walker KB (1987) In vitro steroid sensitivity and interleukin 2 synthesis in normal subjects. Transplant Proc 19: 1564–1565

    Google Scholar 

  14. Kozaki M, Hirano T, Oka K, Homma M, Kang X-X, Sakurai E, Tamaki T, Tamaki I (1989) Prospective endogenous serum cortisol levels as an index of acute rejection and severe infection in renal allograft recipients. Transplant Proc 21: 1864–1866

    Google Scholar 

  15. Langhoff E, Jakobsen BK, Platz P, Ryder L, Svejgaard A (1985) The impact of low doner-specific MLR versus HLA-DR compatibility on kidney graft survival. Transplantation 39: 18–21

    Google Scholar 

  16. Ting A, Morris PJ (1980) Powerful effect of HLA-DR matching on survival of cadaveric renal allografts. Lancet II: 282–285

    Google Scholar 

  17. Opelz G (1985) The collaborative transplant study. Correlation of HLA matching with kidney graft survival in patient with or without cyclosporine treatment. Transplantation 40: 240–243

    Google Scholar 

  18. d'Apice AJF, Sheil AGR, Tait BD, Bashir HV (1984) A prospective randomized trial of matching for HLA-A and B versus HLA-DR in renal transplantation. Transplantation 38: 37–41

    Google Scholar 

  19. Hall BM, Tiller DJ, Hardie I, Mahony J, Mathew T, Thatcher G, Miach P, Thomson N, Sheil AGR (1988) Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. N Engl J Med 318: 1499–1507

    Google Scholar 

  20. Oka K, Hirano T, Shimodaira H, Homma M, Sakurai E, Tamaki T, Kozaki M (1990) Suppression of endogenous cortisol for evaluating pharmacodynamics of prednisolone in early allograft rejection in renal transplantation. Clin Chem 36: 481–486

    Google Scholar 

  21. Hirano T, Oka K, Sakurai E, Tamaki T, Kozaki M (1991) Impaired prednisolone sensitivities of the endocrine system and peripheral-blood lymphocytes are closely related to clinical incidence in renal transplantation. J Pharm Pharmacol 43: 569–573

    Google Scholar 

  22. Oka K, Shimodaira H (1991) Telepharmacodynamics to predict therapeutic effects of glucocorticoids. Lancet 338: 385

    Google Scholar 

  23. Frey BM, Frey FJ (1985) The effect of altered prednisolone kinetics in patients with the nephrotic syndrome and in women taking oral contraceptive steroids on human mixed lymphocyte cultures. J Clin Endocrinol Metab 60: 361–369

    Google Scholar 

  24. Frey BM, Frey FJ, Benet LZ, Cochrum KC (1980) Modification of the mixed lymphocyte reaction for pharmacokinetic assessment of immunosuppressive activity in human plasma. Int J Immunopharmacol 2: 129–134

    Google Scholar 

  25. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A (1989) FK 506 for liver, kidney, and pancreas transplantation. Lancet II: 1000–1004

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kang, X.X., Hirano, T., Oka, K. et al. Role of altered prednisolone-specific lymphocyte sensitivity in chronic renal failure as a pharmacodynamic marker of acute allograft rejection after kidney transplantation. Eur J Clin Pharmacol 41, 417–423 (1991). https://doi.org/10.1007/BF00626362

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00626362

Key words

Navigation